3613 Stock Overview
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Beijing Tong Ren Tang Chinese Medicine Company Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$10.16 |
52 Week High | HK$14.02 |
52 Week Low | HK$8.75 |
Beta | 0.39 |
1 Month Change | 10.43% |
3 Month Change | 9.60% |
1 Year Change | n/a |
3 Year Change | -6.45% |
5 Year Change | -31.90% |
Change since IPO | -31.54% |
Recent News & Updates
Recent updates
Shareholder Returns
3613 | HK Pharmaceuticals | HK Market | |
---|---|---|---|
7D | 7.9% | 3.5% | 4.6% |
1Y | n/a | -5.3% | -1.1% |
Return vs Industry: Insufficient data to determine how 3613 performed against the Hong Kong Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 3613 performed against the Hong Kong Market.
Price Volatility
3613 volatility | |
---|---|
3613 Average Weekly Movement | 3.8% |
Pharmaceuticals Industry Average Movement | 5.9% |
Market Average Movement | 7.4% |
10% most volatile stocks in HK Market | 15.2% |
10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 3613 has not had significant price volatility in the past 3 months.
Volatility Over Time: 3613's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1669 | 798 | Fei Chen | www.tongrentangcm.com |
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services.
Beijing Tong Ren Tang Chinese Medicine Company Limited Fundamentals Summary
3613 fundamental statistics | |
---|---|
Market cap | HK$8.50b |
Earnings (TTM) | HK$540.39m |
Revenue (TTM) | HK$1.52b |
15.7x
P/E Ratio5.6x
P/S RatioIs 3613 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
3613 income statement (TTM) | |
---|---|
Revenue | HK$1.52b |
Cost of Revenue | HK$477.70m |
Gross Profit | HK$1.05b |
Other Expenses | HK$506.85m |
Earnings | HK$540.39m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.65 |
Gross Margin | 68.67% |
Net Profit Margin | 35.44% |
Debt/Equity Ratio | 0.008% |
How did 3613 perform over the long term?
See historical performance and comparisonDividends
3.2%
Current Dividend Yield51%
Payout RatioDoes 3613 pay a reliable dividends?
See 3613 dividend history and benchmarksBeijing Tong Ren Tang Chinese Medicine dividend dates | |
---|---|
Ex Dividend Date | Jun 12 2024 |
Dividend Pay Date | Jun 24 2024 |
Days until Ex dividend | 30 days |
Days until Dividend pay date | 42 days |
Does 3613 pay a reliable dividends?
See 3613 dividend history and benchmarks